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ABSTRACT 
 
Very long chain polyunsaturated fatty acids (VLCPUFAs) such as 
docosahexaenoic acid (DHA, 22:6-4,7,10,13,16,19) and eicosapentaenoic acid (EPA, 
20:5-5,8,11,14,17) have been widely recognized for their health benefits. These omega-
3 fatty acids are important because they are essential parts of cell membranes and are 
involved in mediating various physiological processes in humans and animals. The de 
novo biosynthesis of VLCPUFAs occurs only in certain microorganisms through either 
an aerobic or anaerobic pathway. In the aerobic pathway, various desaturases and 
elongases are involved for the introduction of double bonds and the elongation of chain 
length, while the anaerobic pathway is mediated by a polyunsaturated fatty acid 
synthase (PUFA synthase). In Thraustochytrium, the biosynthesis of VLCPUFAs is 
catalyzed by a PUFA synthase comprising three large subunits, each with multiple 
predicted catalytic domains. However, most of these domains are not biochemically 
characterized and their functions remain unknown. The objective of this project was to 
functionally characterize a malonyl-CoA:ACP transacylase (MAT)-like domain of a 
PUFA synthase from Thraustochytrium by the heterologous expression of the domain 
as a standalone protein in Escherichia coli.  
Bioinformatic analysis was first performed to dissect the MAT-like domain in 
the subunit-B of the PUFA synthase. After that, this domain was expressed as a 
standalone protein in E. coli mutant and wild type strains for complementation and 
activity assays. The results showed that the MAT-like domain could not complement a 
temperature-sensitive mutant (fabDts) defective in malonyl-CoA:ACP transacylase 
activity, disallowing growth at a non-permissive temperature (42 ºC), while an authentic 
MAT domain from subunit-A of the synthase could complement the defective 
phenotype, allowing the growth at both permissive (37 ºC) and non-permissive 
temperature (42 ºC). This result indicated that the MAT-like domain does not function 
as a malonyl-CoA:ACP transacylase. Enzymatic assays showed that the MAT-like 
domain possessed thioesterase activity towards acyl-CoAs and that DHA-CoA was the 
preferred substrate among the acyl-CoAs tested. In addition, expression of this domain 
in an E. coli mutant (fadD) defective in acyl-CoA synthetase activity increased the 
accumulation of free fatty acids (FFAs). Furthermore, site-directed mutagenesis showed 
that the substitution of two residues, serine at 96 (S96) and histidine at 220 (H220), in 
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the MAT-like domain with alanine significantly reduced its activity towards DHA-CoA 
and supressed the accumulation of FFAs in the fadD mutant.  
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1. INTRODUCTION 
 
1.1 Overview 
The biosynthesis of very long chain polyunsaturated fatty acids 
(VLCPUFAs) through the anaerobic pathway is catalyzed by a PUFA synthase in some 
marine microorganisms. Thraustochytrium is a unicellular marine protist that can 
produce more than 50% of its total fatty acids as DHA, an omega-3 VLCPUFA of 
nutritional importance, using a PUFA synthase (Meesapyodsuk & Qiu, 2016). The 
PUFA synthase from Thraustochytrium comprises three subunits: subunit-A, -B and -C 
encoded by three large open reading frames (ORF-A, -B, and -C). The preliminary 
sequence analysis of the PUFA synthase indicates that ORF-A codes for a protein 
containing one -ketoacyl-ACP synthase (KS1) domain, one malonyl-Coenzyme A 
(CoA):ACP transacylase domain (MAT), eight acyl carrier protein (ACP) domains, one 
ketoacyl reductase domain and one dehydratase (DH1) domain; ORF-B codes for a 
protein consisting of two KS domains (KS2, KS3), one MAT-like domain and one 
enoyl-ACP reductase (ER1) domain; and ORF-C codes for a protein consisting of two 
DH domains (DH2, DH3) and one ER domain (ER2) (Meesapyodsuk & Qiu, 2016; 
Zhao, Dauenpen, Qu, & Qiu, 2016). The aim of this study was the bioinformatic 
dissection and functional characterization of the malonyl-CoA:ACP transacylase 
(MAT)-like domain of the PUFA synthase from Thraustochytrium. 
1.2 Hypothesis 
 
The MAT-like domain in the subunit-B of the PUFA synthase from 
Thraustochytrium functions as a thioesterase based on several observations. First, there 
is already a malonyl-CoA:ACP transacylase (MAT) domain in the subunit-A of the 
PUFA synthase for the extender-loading function. Second, the MAT-like domain from 
Subunit-B is divergent from typical MAT domains. Third, VLCPUFAs synthesized by a 
PUFA synthase are released in free fatty acid form, which must come from internal 
thioesterase (TE) activity. Furthermore, this MAT-like domain in the PUFA synthase 
contains a motif GXSXG, which is also conserved in some thioesterases. Therefore, it is 
possible that this MAT-like domain possesses TE activity releasing synthesized 
VLCPUFAs from the ACP domains of the PUFA synthase.  
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1.3 Objectives 
 
The four technical objectives of this research were as follows. 
 
1. To bioinformatically analyze the MAT-like domain of the PUFA synthase from 
Thraustochytrium. 
2. To express the MAT-like domain in E. coli fabD (malonyl-CoA:ACP transacylase), 
tesAtesB (thioesterase) and fadD (acety-CoA synthetase) mutants. 
3. To determine the enzymatic activity of the MAT-like domain by in vitro assays with 
the MAT-like protein expressed in E. coli.  
4. To investigate the functional roles of two conserved residues: Serine96 and 
Histidine220 in the MAT-like domain by site-directed mutagenesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
2. LITERATURE REVIEW 
2.1 Essential fatty acids 
 Essential fatty acids (EFAs) are those that are required for human growth and 
development. However, humans cannot de novo synthesize these fatty acids and have to 
rely on the diet for them to stay healthy (Das, 2006a). EFAs are generally 
polyunsaturated fatty acids (PUFAs) with chain lengths of 18 carbons (18C) or more 
and double bonds of two or more. Although the terms EFAs and PUFAs are used to 
refer to the same type of fatty acids; it is important to note that all EFAs are PUFAs, but 
not vice versa. According to the location of the last double bond to the methyl-end, 
PUFAs can be classified into several families: omega-3 PUFAs, derived from -
linolenic acid (ALA, 18:3-9,12,15); omega-6 PUFAs, derived from linoleic acid (LA, 
18:2-9,12); -7 PUFAs, derived from palmitoleic acid (PA, 16:1-9) and -9 PUFAs, 
derived from oleic acid (OA, 18:1-9). The first two families are EFAs while the latter 
two are not (Das, 2006b). Among omega-3 and omega-6 PUFAs, only LA and ALA are 
considered as strict EFAs as the rest of PUFAs can be synthesized by humans provided 
with these two fatty acids. The rest of fatty acids derived from the two strict EFAs are 
considered as conditional EFAs (Das, 2006b).  
 EFAs, and their derivatives, are biologically active compounds that are involved 
in various physiological processes and possess many health benefits such as the 
reduction of cardiovascular disease, improved brain and vision performance, cancer 
prevention, normal fetus and infant development (Kaur, et al., 2012). Sources for 
omega-6 EFAs are vegetable oils such as corn, soybean and sunflower oil, cereals and 
their baked goods, and animal products (Meyer et al., 2003). For the omega-3 EFAs, 
canola oil, walnuts and marine fish oils are rich sources for these fatty acids (Das, 
2006b). Eicosapentaenoic acid (EPA, 20:5-5,8,11,14,17) and docosahexaenoic acid 
(DHA, 22:6-4,7,10,13,16,19) commonly known as marine omega-3 polyunsaturated 
fatty acids are the most important EFAs for human health. Modern Western diets are 
high in omega-6 fatty acids with potential pro-inflammatory properties and low in 
omega-3 fatty acids with anti-inflammatory properties. Therefore, it is highly desirable 
for humans to intake more omega-3 fatty acids to prevent inflammatory diseases and 
promote overall good health (Simopoulos, 2016). 
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2.2 Very long chain polyunsaturated fatty acids (VLCPUFAs) 
 According to their chain length, polyunsaturated fatty acids can be classified into 
two families, long chain PUFAs with the length from 16 carbons to 18 carbons and very 
long chain polyunsaturated fatty acids (VLCPUFAs) with the length longer than 18 
carbons (Ruxton et al., 2004). Omega-3 VLCPUFAs such as EPA and DHA are 
synthesized from ALA through alternating desaturations and elongations. Omega-6 
VLCPUFAs including arachidonic acid (AA, 20:4-5,8,11,14) are synthesized from LA 
through a similar process. The desaturases and elongases involved in the biosynthesis of 
omega-3 and omega-6 VLCPUFAs from ALA and LA are shared by the two families; 
thus a competition for the same set of enzymes between the two family substrates can 
occur (Koletzko et al., 2008).  
Both omega-3 and omega-6 VLCPUFAs are important for the proper growth 
and development of higher organisms such as humans and animals. They are essential 
components of cell membranes in the retina and brain, and the lack of these fatty acids 
impedes brain development and visual function. In addition, the VLCPUFAs are also 
the precursors of bioactive mediators that are involved in regulating various biological 
processes. Therefore, supplementation of these fatty acids is encouraged for appropriate 
development and enhanced performance of our eyes and central nervous system, as well 
as delayed onset of or treatment of certain chronic diseases (Serhan, et al., 2008), such 
as cardiac disorders, high blood pressure and diebetics (Adarme-Vega et al., 2012).  
2.3 Health benefits of omega-3 VLCPUFAs 
 The potential health benefits of omega-3 VLCPUFAs were first described in the 
late 1970s (Mulvad et al., 1996). Later, Danish investigators linked the lower death rate 
of myocardial infarction in the Inuit population, which they attributed to their fish-based 
diets rich in omega-3 VLCPUFAs (O’Keefe & Harris, 2000). After that, many health 
benefits of omega-3 VLCPUFAs particularly DHA on prevention against cardiovascular 
diseases and brains and eye performance have been examined in animals and humans. 
 
2.3.1 Cardiovascular disease 
 Cardiovascular disease (CDV) is one of the main causes of death in humans, 
accounting for almost 50% of all deaths in developed countries and 25% in the 
developing world. Risk factors, such as poor eating habits, low physical activity, 
drinking and smoking, high blood pressure, diabetes and being overweight can 
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contribute to the development of CDV (Sokola-Wysoczanska et al., 2018). All of these 
factors can result in chronic inflammation, which in turn could lead to the dysfunction 
of the cardiovascular system (Kromhout et al., 2012).  
 Several studies suggest that omega-3 VLCPUFAs can prevent myocardial 
infarction and arrhythmia through the rapid incorporation of these fatty acids in the 
phospholipids of cell membranes affecting their structure and function, and subsequent 
anti-inflammatory effects of derivatives synthesized from these fatty acids (Din et al., 
2004).  Although the precise mechanisms of omega-3 VLCPUFAs on cardiovascular 
systems are not fully understood; studies have shown that when humans take a diet 
supplemented with fish oil, a reduction in the platelet-monocyte aggregation, a potential 
cardiovascular benefit, has been observed (Din et al., 2008). 
 Another mechanism of omega-3 VLCPUFAs could be due to their anti-
arrhythmic properties. Studies report that this type of fatty acid exerts anti-arrhythmic 
effects by modulating of myocyte electrophysiology, reducting the activity of 
membrane sodium channels in the cardiomyocyte, and regulating the activity of L-type 
calcium channels, thereby stabilizing the myocyte electrical excitability and preventing 
arrhythmia (Endo & Arita, 2016). However this is controversial as other studies also 
show that supplementation with omega-3 VLCPUFAs for a short period of six months 
to one year did not have any anti-arrhythmic effects (Bianconi et al., 2011; Macchia et 
al., 2013) indicating that the health promoting benefits of these molecules occurs 
through alternative and as-of-yet unidentified mechanisms. In addition, the anti-
inflammatory properties of omega-3 VLCPUFAs can provide cardiovascular protective 
effects. Omega-3 VLCPUFAs, particularly EPA, decrease the production of 
inflammation-related cytokines such as tumor necrosis factor- (TNF-). TNF- 
expression is regulated by nuclear factor-B (NF-B). IB, the inhibitory subunit of the 
NF-B complex is kept inactive in the cytoplasm under non-stress conditions. The 
phosphorylation of IB by an IB kinase leads to the activation of NF-B and 
subsequently up-regulating the expression of TNF-. Other studies also revealed that 
omega-3 VLCPUFAs can exert anti-inflammatory effects through the suppression of the 
NF-B and TNF-α expression (Gomaa & Abd El-Aiz, 2016; Y. Zhao et al., 2004). 
 Omega-3 VLCPUFAs anti-inflammatory properties (Figure 2.1) have been 
attributed to the prevention of arachidonic acid (AA) conversion into pro-inflammatory 
2-series prostaglandins (PG2) and 4-series leukotrienes (LT4) as catalyzed by 
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phospholipase A2, cyclooxygenase and 5-lipoxygenase (Simopoulos, 2016). These 
enzymes are also involved in the production of anti-inflammatory prostaglandins such 
as 3-series PG3 and thromboxanes (TX3) and leukotrienes 5-series LT5 (Endo & Arita, 
2016) using EPA as a substrate. DHA can also serve as a precursor of anti-inflammatory 
mediators such as resolvins, protectins and maresins, which have pro-resolving and 
regenerative properties (Serhan, 2014). 
 
Figure 2.1 Pro-inflammatory and anti-inflammatory products of omega-6 and omega-3 
VLCPUFAs. Adapted from Endo & Arita, 2016. 
 
2.3.2 Brain function 
 Fatty acid composition of the brain consists of high levels of palmitic acid 
(16:0), AA, DHA and a lower level of EPA. DHA is 250-300 times higher than EPA 
(Chen et al., 2009). This ratio is probably conserved in higher animals (Crawford et al., 
1976).   
 Omega-3 VLCPUFAs are essential components of cell membranes in human 
neurons, and play an important role in the fluidity modulation, permeability and protein 
activity in the neuronal membrane (Stillwell et al., 2005). It has been observed that 
when DHA was administered in rat neural stem cells, it promote neurogenesis, a process 
by which neural stem cells differentiate into new neurons, and the damaged brain tissue 
is self-repaired (Dyall, 2015). Neurogenesis promoted by DHA could be due to a 
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decreased level of Hes1 (hair and enhancer of split-1), a transcriptional repressor that 
inhibits neuronal differentiation (Katakura et al., 2013). However, it is still unclear if the 
omega-3 VLCPUFAs exert these effects by themselves or through their derived 
mediators.  
 In the aging brain, the anti-inflammatory properties of omega-3 VLCPUFAs 
have positive effects on age-related neural impairments such as decreased learning and 
memory (McGahon et al., 1999). In particular, docosapentaenoic acid (DPA, 22:5-
7,10,13,16,19) and EPA have been shown to decrease the age-related microglial 
activation, reverse age-related impairment in spatial learning and reduce the associated 
oxidative stress when 200 mg/kg/day of these fatty acids are supplemented in rats 
(Kelly et al., 2011). 
 
2.3.3 Retina function  
 DHA is an essential component of the membrane of photoreceptor cells in retina 
and helps to maintain membrane flexibility. Thus, it plays an important role in retina 
function (Garelli et al., 2006).  Another important function of omega-3 VLCPUFAs is 
their anti-inflammatory effects in retina. The presence of high levels of omega-3 
VLCPUFAs inhibit the formation of pro-inflammatory omega-6 AA derivatives through 
competition for cyclooxygenase (COX) and lipoxygenase (LO) (Calder, 2003). In 
addition, DHA prevents the induced apoptotic death of photoreceptors by reducing 
oxidative damage of the mitochondrial membrane (Rotstein et al., 2003). Treatment 
with algae oil high in omega-3 VLCPUFAs has been shown to reduce light-induced 
apoptosis and angiogenesis in rabbits retina through the suppression of the expression of 
inteleukin-1 , TNF- and COX2 (Deng et al., 2018). 
  Although vast scientific evidence suggests that omega-3 VLCPUFAs can aid in 
the maintenance of retina health, research results are not conclusive on the benefits of a 
diet high in these fatty acids for the prevention of age-related macular degeneration 
(AMD) (Souied et al., 2015), a medical condition produced by the loss of vision in the 
central region of the retina known as the macula, which is one of the principal causes of 
blindness in the elderly (Tan et al., 2018). Therefore, more research would be required 
to establish the benefits of omega-3 VLCPUFAs against macular degeneration.   
 
2.3.4 Fetal development 
 Supplementation with omega-3 VLCPUFAs during pregnancy and maternal 
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stages provides positive effects on the development of fetal and child brains, and 
cognitive activity (Saccone et al., 2016). The report by Olsen et al (1986) demonstrated 
that the consumption of omega-3 VLCPUFAs prolonged gestation in human beings by 
reducing the production of PG2 (Olsen et al., 1986). It is noteworthy that the fetus and 
neonate can synthesize short chain fatty acids (SCFAs) and mono-unsaturated fatty 
acids (MUFAs), but their ability to produce VLCPUFAs is limited. Therefore, it is 
important that they obtain these fatty acids from breast milk which is in turn derived 
from mother’s diet (Mennitti et al., 2015). 
 Supplementation of DHA during pregnancy can activate the peroxisome 
proliferator activated receptors (PPARs), which are nuclear receptors regulating the 
expression of anti-inflammatory genes through the ligand-binding with VLCPUFAs; 
this activation has been beneficial to the lung development of fetus. When there is 
condition of intrauterine growth restriction, supplementation of omega-3 VLCPUFAs 
can ameliorate its effects and facilitate the normal development of baby lungs (Joss-
Moore et al., 2011).  Another benefit of the consumption of omega-3 VLCPUFAs 
during pregnancy is the reduction of fat accretion and adiposity in the offspring. 
Sardinha, et al (2013) fed rats with a diet with 8% of fish oil during day 1 to 12 of 
pregnancy and found fat accretion in male offspring was reduced, although this effect 
was not seen in female offspring (Sardinha et al., 2013).  Furthermore, the 
supplementation of omega-3 PUFAs can help ameliorate fetus damage caused by a 
diabetic condition in the mother. The incorporation of flax seeds rich in an omega-3 
fatty acid in a diet administered to diabetic pregnant rats resulted in a decrease in the 
activity of antioxidant enzymes such as catalase and superoxide dismutase, and the 
malondialdehyde and glutathione levels, indicators of oxidative stress, suggesting that 
omega-3 fatty acids could provide prevention against the negative effect of diabetes 
mothers on their offspring (Makni et al., 2011).  
2.4 Sources of VLCPUFAs 
The most common source of VLCPUFAs for humans and animals are fish, such 
as salmon, mullet and mackerel (Adarme-Vega et al., 2012); however, the increasing 
demand for these fatty acids in dietary supplementation has placed high presure on this 
source. First, as the fish population in oceans is over-exploited, the sustainability of this 
source is under pressure. Second, farmed fish require omega-VLCPUFAs for normal 
growth and development, but are unable to synthesize these compounds, and must rely 
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on feed supplementation. Finally, as marine fish species rich in omega-3 VLCPUFAs 
are at the top of the food chain in oceans, the availablity of  effective VLCPUFAs, 
particularly DHA, varies  with growth seasons and changes of upstream species in the 
food chain (Mohanty et al., 2016; Walsh & Metz, 2013). Therefore, there is a need for 
seeking alternative and sustainable sources for these fatty acids.  
One possible alternative source for VLCPUFAs is the native microbial 
VLCPUFA producers such as Schizochytrium and Thraustochytrium that can 
accumulate a very high level of DHA (36% and 50% of the total fatty acids, 
respectively) (Meesapyodsuk & Qiu, 2016; B. Zhao et al., 2018). Another possible 
source for these fatty acids is transgenic oilseeds producing these fatty acids by 
metabolic enginering of the biosynthetic pathways of microbial origin in plants. 
2.5 Fatty acid biosynthesis 
De novo biosynthesis of long chain fatty acids in yeast and vertebrates is 
catalyzed by a large enzyme called Type I fatty acid synthase (FAS). However, the 
same biosynthesis of these molecules in plants and bacteria is catalyzed by a protein 
complex comprising multiple discrete enzymes known as Type II fatty acid synthase. 
Although the structure and organization of these fatty acid synthases are different, the 
biochemical process for fatty acid biosynthesis is similar (Verwoert et al., 1994).  
The biosynthesis of long chain fatty acids comprises four basic reactions (Figure 
2.2). The first biochemical reaction is the condensation of acyl-ACP with malonyl-ACP 
by 3-keto-acyl-ACP synthase (keto synthase or KS) producing 3-keto-acyl-ACP. Next, 
3-keto-acyl-ACP is reduced by 3-keto-acyl-ACP reductase (KR), which is then 
dehydrated by 3-hydroxy-acyl-ACP dehydratase (DH) to a 2,3-trans-enoyl-ACP. 
Finally, the enoyl-ACP is reduced to saturated acyl-ACP with the extension of two 
carbons by 2,3-trans-enoyl reductase (ER).  
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Figure 2.2 Biosynthesis of long chain fatty acids. Adapted from Meesapyodsuk & Qiu, 
2016. 
 
In plants, these four reactions are catalyzed by four individual enzymes 
constituting a Type II fatty acid synthase and the end products of biosynthesis are 16:0 
and 18:0 fatty acid thioesters (fatty acyl-acyl carrier protein (ACP)). After synthesis, 
these fatty acids can be desaturated by a soluble stearoyl-ACP desaturase in chloroplast 
stroma, to produce 16:1-ACP and 18:1-ACP, respectively. The two monounsaturated 
fatty acids are then moved out of chloroplast to cytosol where two membrane-bound 
desaturases (12 and 15 desaturase) introduce two additional double bonds 
sequentially on 18:1-9, producing 18:2-9,12 (LA) and 18:3-9,12,15, respectively 
(Wallis et al., 2002). 
In animals, the reactions involved in fatty acid biosynthesis are catalyzed by four 
main catalytic domains (KS, KR, DH and ER) in a Type I fatty acid synthase. Besides 
the four catalytic domains, this large enzyme also contains other important domains 
involved in fatty acid synthesis such as ACP, malonyl-CoA:ACP transacylase (MAT) 
and thioesterase (TE). In PUFA synthases, an ACP domain can be present several times 
in tandem, which carries and delivers growing fatty acyls to the different catalytic sites 
of the fatty acid synthase (Jiang et al., 2009). The malonyl-CoA:ACP transacylase 
domain selects an extender unit from acyl-CoAs and discharges it to ACP. TE 
hydrolyzes acyl-ACP, releasing free fatty acids (Keatinge-Clay, 2012). 
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2.5.1 Malonyl-CoA:ACP transacylase (MAT)  
Malonyl-CoA is a two-carbon donor molecule, product of the carboxylation of 
acetyl-CoA through the activity of acetyl-CoA carboxylase (ACC). This molecule 
serves as a control point between lipogenesis and –oxidation and is important for fatty-
acid biosynthesis (Cheng et al., 2013). The malonyl moiety of malonyl-CoA is 
transferred to a holo-ACP, producing malonyl-ACP, which serves as an extender 
substrate for the biosynthesis of fatty acids (Voelker & Davies, 1994). This transfer is 
catalyzed by malonyl-CoA:ACP transacylase (MAT) either from a discrete enzyme in a 
Type II fatty acid synthase complex or from a MAT domain in a Type I fatty acid 
synthase (Figure 2.3, Liu et al., 2006). 
Figure 2.3 Reaction of the MAT. Adapted from Yu et al., 2011.  
 
The MAT protein, also known as FabD in E. coli, is essential for fatty acid 
biosynthesis (Cheng et al., 2013). The genetic inactivation of fabD is lethal in the 
bacterium (Sun et al., 2012). The crystal structure analysis of FabD shows that it has the 
core structure of a / hydrolase with  strands connected by  helices and a catalytic 
triad: Ser-His-Asp (Liu et al., 2006; Serre et al., 1995). The catalytic reaction comprises 
two steps. First, a MAT binds a malonyl-CoA to form a malonyl-MAT intermediate. 
Second, the MAT transfers the malonyl moiety from the intermediate to a holo-ACP 
(Sun et al., 2012).  
 In marine VLCPUFA producers Thraustochytrids, including Schizochytrium and 
Thraustochytrium, a discrete MAT from Schizochytrium was recently identified and 
functionally characterized. It contains two conserved motifs: FPGQG involved in 
catalysis and GHSLGE involved in ACP-binding (Cheng et al., 2013). Two putative 
MAT domains in a PUFA synthase responsible for the biosynthesis of VLCPUFAs in 
Thraustochytrium have also been identified. One MAT domain resides in Subunit-A 
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while the other is located in Subunit-B (Meesapyodsuk & Qiu, 2016). However, their 
exact functions are currently unknown. 
2.5.2 Thioesterase (TE)  
Thioesterases or thioester hydrolases, are a large group of enzymes that release 
acyl moieties from the phosphopantetheine of ACP or CoA (Smith & Tsai, 2007) 
through hydrolysis of the thioester bond between a carbonyl group and a sulfur atom. 
Some thioesterases can also release the acyl moiety from glutathione and ubiquitin 
(Cantu et al., 2010). E. coli has two major acyl-CoA thioesterases, thioesterase I and II, 
encoded by TesA and TesB genes, respectively; however, neither is essential for the 
bacterial growth and development. The thioesterase I (TesA) consists of 182 amino 
acids (Cho & Cronan, 1993) and is a monomeric enzyme located in the cell periplasm 
for hydrolyzing acyl-thioester bonds to produce free fatty acids (Lennen & Pfleger, 
2012). The active site of thioesterase I is found on the motif Gly-Asp-Ser-Leu-Ser-Ala-
Gly with Ser being the active residue. As a major thioesterase in E. coli, one of its 
possible roles is to modulate the chain length of fatty acids synthesized. However, this 
function has been questioned, as the thioesterase is a periplasm enzyme, while fatty acid 
synthesis occurs in the cytosol. In addition, the overexpression or inactivation of the 
thioesterase does not change the fatty acid profile (Cho & Cronan, 1993). Nevertheless, 
it has substrate specificity towards C12 to C18 acyl chains and may play a role in fatty 
acid synthesis (Naggert et al., 1991; Zheng et al., 2004). E. coli thioesterase II (TesB) is 
a 286 polypeptide and forms a homo-tetramer for the function (Naggert et al., 1991). It 
can cleave C6 to C18 acyl-CoA esters (Zheng et al., 2004). Thus, it seems unlikely that 
this thioesterase is a chain-terminating enzyme in the fatty acid synthesis.  
Thioesterases have been classified into 23 families based on their tertiary 
structures. Families 14 and 19 correspond to thioesterases that hydrolyze acyl groups 
and ACP (Figure 2.4) (Cantu et al., 2010). The structure of acyl-ACP thioesterases in 
bacteria and plants possesses /-hydrolase folds that are in charge of fatty acid or 
polyketide synthesis termination. In plants, two major thioesterases FatA and FatB have 
been identified and they hydrolyze C8-C18 acyl-ACP thioesters (Cantu et al., 2010).  
 Like other /-hydrolases, thioesterases employ a nucleophile (Ser, Cys or 
Asp)-His-acid triad for catalysis. The first residue of the triad is often a serine as a 
nucleophile, the second residue is always a histidine, and the third is an acidic amino 
acid. The nucleophile is located in “nucleophile elbow” and can be reached by a 
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substrate and a water molecule for hydrolysis (Nardini & Dijkstra, 1999). Commonly, 
the acid residue stabilizes the His, which is a basic amino acid and accepts a proton 
from the nucleophile to form an intermediate with the substrate to be further attacked by 
a water molecule (Cantu et al., 2010). 
 
Figure 2.4 Reaction catalyzed by thioesterase. Adapted from iGEM, 2017. 
Acyl-ACP thioesterase is hypothesized to be required for releasing VLCPUFAs 
from an ACP domain of a PUFA synthase at the end of the VLCPUFA biosynthesis, 
which possibly is catalyzed by internal thioesterase activity of the synthase (Metz et al., 
2009).  However, a domain inside a PUFA synthase responsible for this activity has not 
been identified in Thraustochytrids.  Photobacterium profundum, a deep-sea bacterium, 
can also produce omega-3 VLCPUFAs using a PUFA synthase. However, no 
thioesterase-like domain is present in the synthase. Rodríguez-Guilbe et al., (2013) 
identified a discrete thioesterase near the PUFA synthase cluster in the bacterium and 
showed that it has preferential activity towards long-chain fatty acyl-CoA substrates.  
2.6 VLCPUFAs biosynthesis 
Omega-3 VLCPUFAs are mainly de novo synthesized in marine 
microorganisms and subsequently go through the food chain from zoo-plankton to 
carnivorous fish (Walsh et al., 2016). There are two different biosynthetic pathways to 
produce the VLCPUFAs in these microorganisms, aerobic and anaerobic (Qiu, 2003; 
Swanson et al., 2012).  
 
2.6.1 Aerobic pathway 
The aerobic pathway to produce VLCPUFAs occurs in the endoplasmic 
reticulum of eukaryotic cells where double bonds are introduced by desaturases (Qiu et 
al., 2011), and fatty acid chain lengths are determined by elongases (Figure 2.5). As 
mentioned previously, fatty acids are synthesized from acetyl-CoA and malonyl-CoA 
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through a series of reactions performed by the fatty acid synthase complex or enzymes. 
The resulting stearic acid (18:0) is then desaturated by a 9 desaturase to form OA, 
which further can be desaturated to produce the two PUFAs families: omega-3 and 
omega-6. the biosynthesis of VLCPUFAs in the aerobic pathway usually starts with the 
omega-6 LA (18:2-9,12) which can be desaturated by a 15 desaturase to form omega-3 
ALA (18:3-9,12,15). LA and ALA are substrates of the same enzymes to produce 
VLCPUFAs. The first step is a desaturation by 6 desaturase that introduces a double 
bond in the 6 carbon. This desaturation is followed by an elongation. Subsequently, a 
5 desaturation and a new elongation takes place, finally a 4 desaturation occurs to 
form DPA and DHA, respectively (Ratledge, 2004).  
 
Figure 2.5 Aerobic pathway for the biosynthesis of VLCPUFAs in Thraustochytrium. 
Adapted from Qiu, 2003. 
 
2.6.2 Anaerobic pathway 
The anaerobic pathway mostly occurs in prokaryotic and eukaryotic microbes 
where the biosynthesis of VLCPUFAs is catalyzed by a polyunsaturated fatty acid 
(PUFA) synthase. Similar to polyketide synthase (PKS) and Type I fatty acid synthase 
(FAS), PUFA synthase is a mega-enzyme comprising more than one modules or 
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subunits, each with multiple catalytic domains such as ketosynthase (KS), malonyl-
CoA:ACP transacylase (MAT), acyltransferase (AT), dehydratase (DH), ketoreductase 
(KR), enoylreductase (ER) and acyl carrier protein (ACP) (Jiang et al., 2008) (Figure 
2.6). These domains can be arranged in different orders, but they are well conserved in 
PUFA synthases across marine microorganisms (Shulse & Allen, 2011).  
The biosynthetic process takes place through assembling a two-carbon unit 
precursor from malonyl-CoA, and double bonds are introduced during the chain 
extending process (Walsh et al., 2016). The synthesis of one DHA molecule requires 
one primer acetyl-CoA and ten extenders malonyl-CoA and as well as sixteen 
nicotinamide adenine dinucleotide phosphate (NADPH) molecules, with no 
intermediate precursors involved (Walsh & Metz, 2013). A distinguish feature of PUFA 
synthases is the presence of multiple (5-10) tandem ACP domains, which increases the 
biosynthetic capacity of VLCPUFAs (Jiang et al., 2008). The final products are in free 
fatty acid form (Walsh & Metz, 2013).   
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Anaerobic pathway for the biosynthesis of VLCPUFAs in Thraustochytrium. 
Adapted from Qiu, 2003. 
2.7 Thraustochytrium  
Thraustochytrium is a unicellular marine protist that belongs to the group of 
heterokonts called Thraustochytrids. It can produce a higher level of DHA (Zhang et al., 
2018) than other species such as bacteria, fish, fungi, and microalgae (Adarme-Vega et 
al., 2012). The production of DHA can reach up to 56% of the total fatty acids 
(Meesapyodsuk & Qiu, 2016) in this species. Thraustochytrium can be cultivated in 
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simple media and has been used as a commercial source for DHA. However, the 
extraction of DHA from the cell requires a high input in energy and is time-consuming 
in preparing the dried biomass and cell lysis (Lowrey et al., 2016). 
2.8 Thraustochytrium PUFA synthase 
Interestingly, both aerobic and anaerobic pathways for the biosynthesis of 
VLCPUFAs co-exist in Thraustochytrium. The biosynthesis of DHA in the aerobic 
pathway goes through alternating desaturations and elongations to the final products: 
DPA and DHA (Qiu et al., 2001). Most desaturases including 4, 5, 6 and 3, and 
elongases including 5 and 6 in this pathway have been identified (Meesapyodsuk & 
Qiu, 2016). The anaerobic pathway for the VLCPUFA biosynthesis (Figure 2.7) goes 
through the reiterative cycles of four reactions starting from acetate as the substrate: 
condensation (KS), ketoreduction (KR), dehydration (DH) and enoylreduction (ER); all 
are performed by a single PUFA synthase. The synthase is comprised of three subunits 
or open reading frames (ORF), each with multiple catalytic domains. Based on the 
presence of characteristic active sites, these catalytic domains were predicted (Figure 
2.7, Meesapyodsuk & Qiu, 2016). However, most of these domains are not 
biochemically characterized. 
 
Figure 2.7 Structure of the PUFA synthase from Thraustochytrium. Adapted from 
Meesapyodsuk & Qiu, 2016. 
  
 17 
3. MATERIALS AND METHODS 
3.1 E. coli strains 
E. coli Top10 was purchased from Invitrogen Biotechnology Co. (Grand Island, 
NY, USA). E. coli fabD mutants (ΔfabD) were obtained from the Coli Genetic Stock 
Center from the Yale University (New Haven, CO, USA). An E. coli tesAtesB double 
mutant (ΔtesAtesB) and parental wild type strain were kindly provided by Dr. John 
Cronan, University of Illinois (Urbana-Champaign, IL, USA). E. coli fadD strain was 
provided by Dr. Pamela Silver, Harvard Medical School (Boston, MA, USA) (Torella et 
al., 2013). E. coli SHuffle strain was acquired from New England BioLabs (Ipswich, 
MA, USA). E. coli BL21 Star (DE3) and Rosetta (DE3) were also purchased from 
Invitrogen Biotechnology Co. E. coli C41 and C43 were obtained from Lucigen 
(Middleton, WI, USA). The genotypes of the strains are shown in Table 3.1.  
 
Table 3.1 Genotypes of E. coli mutant and parental strains. 
Strains Genotype 
ΔfabD parental 
araC14, lacY1, tsx-57, glnX44(AS), gltA5, galK2(Oc), Rac-0, rfbC1, 
rpsL20(strR), xylA5, mtl-1, lldD1, thiE1, tfr-5 
ΔfabD 
F-, araC14, lacY1, tsx-57, glnX44(AS), gltA5, galK2(Oc), fabD89(ts), 
rpsL20(strR), xylA5, mtl-1, lldD1, thiE1, tfr-5 
ΔtesAtesB parental  K-12 F
–
 λ– ilvG– rfb-50 rph-1 
ΔtesAtesB  F
–
,  ΔtesA::cat ΔtesB, λ
-
, λ– ilvG– rfb-50 rph-1 
 fadD 
F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 [lacI lacUV5-
T7p07 ind1 sam7 nin5]) [malB+]K-12(λS) ΔfadD 
SHuffle  
F´ lac, pro, lacIQ / Δ(ara-leu)7697 araD139 fhuA2 lacZ::T7 gene1 Δ(phoA) 
PvuII phoR ahpC* galE (or U) galK λatt::pNEB3-r1-cDsbC (SpecR, lacIq) 
ΔtrxB rpsL150(StrR) Δgor Δ(malF)3 
BL21 Star (DE3) fhuA2 [lon] ompT gal [dcm] ΔhsdS 
Rosetta (DE3) F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE (CamR) 
C43 F – ompT hsdSB (rB- mB-) gal dcm (DE3) 
C41 F – ompT hsdSB (rB- mB-) gal dcm (DE3) 
Arctic 
E. coli B F– ompT hsdS(rB- mB-) dcm+ Tetr gal λ(DE3) endA Hte [cpn10 BB 
cpn60 Gentr] 
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3.2 Plasmids 
The pCDFDuet-1 vector with the ORF-B of the PUFA synthase from 
Thraustochytrium sp. 26185 was obtained from our previous research (Meesapyodsuk 
& Qiu, 2016). Expression vectors, pBAD, and pET28a were purchased from Invitrogen 
Co. (Carlsbad, CA, USA). The pBAD vector was used to express foreign gene(s) under 
the control of an inducible system by arabinose with ampicillin resistance selection. The 
pET28a vector was used to clone a gene under the control of a strong T7 promoter, 
induced by isopropyl β-D-1-thiogalactopyranoside (IPTG) with kanamycin resistance 
selection.  
3.3 Luria Bertani (LB) medium and agar plates 
 LB medium was purchased from Thermo Fisher Scientific (Waltham, MA, 
USA) and prepared according the manufacturer instruction. For example, 25 g of LB 
medium powder were dissolved in 1 L of deionized water and then autoclaved at 120 ºC 
for 20 min. For agar plates, 1 % of agar was added to the LB medium, autoclaved at the 
same condition and plated in 10 cm plastic plates. For antibiotic plates, final 
concentrations for kanamycin, ampicillin and chloramphenicol were 50, 100 and 25 
g/mL, respectively.  
3.4 Chemical competent cells  
A single colony of any E. coli strain used was inoculated into 5 mL of LB 
medium with or without antibiotics and incubated at 37 C overnight. Three mL of 
overnight culture were inoculated into 30 mL of LB medium and incubated at 37 C 
until an OD600  0.4 was reached. After that, the culture was cooled down on ice and 
then centrifuged at 4 C for 10 min to pellet cells. The cell pellet was resuspended in 10 
mL of ice cold 50 mM CaCl2 solution and incubated at 4 C for 30 min. The suspension 
was centrifuge again at 4 C for 5 min and the cell pellet was resuspended in 1 mL 
glycerol.  Aliquots of 50 L or 25 L glycerol suspension were prepared and store at -
80 C for future transformation (Ausubel et al., 2003). 
3.5 Sequence analysis of the PUFA synthase in Thraustochytrium 
 The sequence of the polyunsaturated fatty acid synthase from Thraustochytrium 
sp. ATCC 26185 (GenBank accession no. AOG21005.1) in the National Center for 
Biotechnology Information website (NCBI) was analyzed by bioinformatics tools which 
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included BLASTp (NCBI), MegAlign (DNASTAR), and SWISS-MODEL. The 
boundaries of the MAT-like domain were determined by sequence alignment and 
homology modeling. The complete amino acid sequence of the ORF-B of the PUFA 
synthase was used as a query to search NCBI protein database by BLASTp with the 
default algorithm parameters to identify the MAT-like domain and its homologous 
sequences. Two different lengths of the MAT-like domain were used for the protein 
modelling by SWISS-MODEL, one from amino acid 1048 to 1390 and the other from 
1063 to 1390 of the Subunit-B of the PUFA synthase. Three templates with the highest 
percentage of identity to the domain used for the modelling were the MAT proteins 
from Streptococcus pneumoniae (17.99%), Coxiella burnetti (18.56%) and E. coli 
(17.79%). Similar stereospecific structures were used to determine the borders of the 
MAT-like domain. Sequence alignment of the MAT-like domain with biochemically 
characterized MAT and TE proteins was performed using MegAlign to identify the 
conserved motifs. Alignments were done using the ClustalW method with the slow-
accurate option to obtain a precise alignment even if the sequences were highly 
divergent. 
3.6 Enzymes, primers and kit for DNA amplification and purification  
DNA purification kit was acquired from Bio Basic Inc. (York, ON, Canada). 
Primers for PCR were synthesized by Sigma-Aldrich (St. Louis, MO, USA) as shown in 
Table 3.2. Q5 polymerase, restriction enzymes and dNTP were purchased from New 
England Biolabs (NEB) (Ipswich, MA, USA). HP Taq DNA polymerase was purchased 
from Bio Basic Inc. T4 ligase was acquired from Thermo Fisher Scientific. EcoRI, 
HindIII and BglII restriction enzymes were purchased from NEB. 
 
Table 3.2 Primers used for MAT amplifications and site-directed mutagenesis. 
Name Sequence (5’  3’) Annotation 
MAT-like (ORF-B) F GAATTCATGTACGGCGAGGGC EcoRI site (underline) 
MAT-like (ORF-B) R AAGCTTCTAGAGCTTGACGATGGT   HindIII site (underline) 
MAT (ORF-A) F GAATTCATGTTCAGCGAGGTC EcoRI site (underline) 
MAT (ORF-A) R AAGCTTCTACCACTTGTCAAAGCC HindIII site (underline) 
FabD (E. coli) F AGATCTATGACGCAATTTGCA BglII site (underline) 
FabD (E. coli) R GAATTCTTAAAGCTCGAGCGC EcoRI site (underline) 
MAT-like S96A F TTCGGCCTCGCCCTCGGCGAGAT Mutation site (underline) 
MAT-like S96A R ATCTCGCCGAGGGCGAGGCCGAA Mutation site (underline) 
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Table 3.2 Primers used for MAT amplifications and site-directed mutagenesis 
(continued). 
Name Sequence (5’  3’) Annotation 
MAT-like H220A F AGGGCATGTGCGGCGCCTGCC Mutation site (underline) 
MAT-like H220A R GGCAGGCGCCGCACATGCCCT Mutation site (underline) 
pET28a F GGCCACGATGCGTCCGGCGTAGAGG For colony PCR 
pET28a R CAGTGGTGGTGGTGGTGGTGCTCGAGT For colony PCR 
pBAD F GGGCTAACAGGAGGAATTAACCATGGGGGG For colony PCR 
pBAD R TTCACTTCTGAGTTCGGCATGGGGTCAGG For colony PCR 
 
3.7 Construction and transformation of recombinant plasmids 
Amplification of the MAT-like domain and control genes was performed using 
the Q5 High-Fidelity DNA Polymerase from New England Biolabs using primers listed 
in Table 3.2 under conditions shown in Tables 3.3 (composition) and 3.4 
(thermocycler). After amplification, amplicons were digested according to the 
conditions shown in Table 3.5 with the restriction enzymes specified in Table 3.2. For 
the digestion of MAT-like (ORF-B), MAT (ORF-A) and MAT-like S96A/H220A 
mutant domains, EcoRI and HindIII restriction enzymes were used, and for FabD (E. 
coli) digestion, BglII and EcoRI restriction enzymes were employed at 37 ºC overnight. 
After digestion, the amplicons were ligated to the expression vectors using T4 ligase 
according to the composition shown in Table 3.6 at 4 ºC overnight.  
 
Table 3.3 Q5 polymerase PCR reaction setup. 
Reagent 20 L reaction Final Concentration 
5X Q5 reaction buffer 4 L 1X 
5X Q5 High GC Enhancer 4 L 1X 
10 mM dNTPs 0.4 L 200 M 
10 M Forward Primer 1 L 0.5 M 
10 M Reverse Primer 1 L 0.5 M 
Template DNA  1 ng 
Q5 High-Fidelity DNA Polymerase 0.2 L 0.02 U/L 
DMSO  5% 
Nuclease-Free Water Up to 20 L  
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Table 3.4 Q5 PCR thermocycling conditions. 
Step Temperature (ºC) Time 
Denaturation 98 30 s 
Annealing for MAT-like 68 30 s 
Annealing for MAT 64 30 s 
Annealing for fabD 62 30 s 
Extension 72 2 min 
 
Table 3.5 Enzymatic digestion reaction setup. 
Reagent 50 L reaction 
DNA Up to 1 g 
10X Reaction Buffer 5 L 
Enzyme(s) 10 units 
Nuclease-Free Water To 50 L 
 
Table 3.6 Ligation reaction setup. 
Reagent 20 L reaction 
5X ligase reaction buffer 4 L 
Insert:Vector Molar Ratio 3:1 
Total DNA 0.1 g 
T4 DNA ligase Up to 20 L 
Nuclease-Free Water 1 L 
 
Two plasmids pBAD, and pET28a were used to express the MAT-like domain 
as a standalone protein in E. coli. pBAD (4092 bp) was used to express the MAT-like 
domain from ORF-B and a MAT domain from ORF-A of the PUFA synthase as well as 
E. coli FabD gene under an arabinose-inducing promoter for complementation assays in 
E. coli mutants (Figure 3.1).  pET28a (5369 bp) was used to express the MAT-like 
domain under a T7 promoter in E. coli SHuffle strain for activity assays (Figure 3.2).   
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Figure 3.1 Physical map of recombinant plasmid pBAD/MAT-like. 
 
Figure 3.2 Physical map of recombinant plasmid pET28a/MAT-like. 
 
The recombinant plasmids were transformed into E. coli strains by a chemical 
method. Approximately 10 ng of each construct was pipetted into 100 L of chemical 
competent cells. The mixture was placed on ice for 10 min, and then heat-shocked at 42 
ºC for 45 seconds. After that, 1 mL of LB broth was added, and the cells were incubated 
at 37 ºC for 1 h with shaking. The cell culture was spread on LB agar plates with 
appropriate antibiotic and incubated at 37 ºC overnight to select the transformants 
(Ausubel et al., 2003). 
A colony PCR method was used to screen for authentic transformants. A single 
colony of E. coli transformants was scraped from an overnight plate and dispersed into 
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the PCR master mix. The remainder was inoculated into 2 mL of LB medium (with 
antibiotics if necessary) and incubated at 37 ºC overnight (Bergkessel & Guthrie, 2013). 
The colony PCR was performed using HP Taq DNA polymerase and primers listed 
above. The reaction setup was shown in Table 3.7 and the thermocycling conditions 
were the same as in Table 3.4. After colony PCR, the plasmids from the positive 
colonies were extracted using plasmid extraction kit from Bio Basic Inc. and digested 
using appropriate restriction enzymes to confirm structures. The positive plasmids were 
sent to the National Research Council Canada (NRC, Saskatoon, SK, Canada) for 
sequencing to confirm the correct of recombinant sequences. 
 
Table 3.7 HP Taq DNA polymerase PCR reaction setup. 
Reagent 20 L reaction 
Final 
Concentration 
10X Taq reaction buffer 2 L 1X 
20 mM MgSO4 2 L 2 mM 
10 mM dNTPs 0.4 L 200 M 
10 M Forward Primer 1 L 0.5 M 
10 M Reverse Primer 1 L 0.5 M 
Template DNA 0.5 L of overnight culture   
Taq DNA polymerase 0.08 L 0.4 U/L 
DMSO  5% 
Nuclease-Free Water Up to 20 L  
  
3.8 Complementation assays in E. coli fabD (ΔfabD) mutant with MAT-like 
domain 
An E. coli ΔfabD mutant used for the complementation assay contains a 
thermolabile malonyl-CoA:ACP transacylase (MAT) resulting in defective fatty acid 
synthesis and temperature-sensitive growth (Semple & Silbert, 1975). Specifically, it 
could grow only at 37 ºC (permissive temperature), but not at 42 ºC (non-permissive 
temperature) (Simon & Slabas, 1998). This conditional mutant was used for the 
complementation test because the complete genetic inactivation of the MAT gene was 
lethal in E. coli (Liu et al., 2006).   
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Two positive controls, pBAD_FabD expressing wild type FabD and 
pBAD_MAT expressing the MAT domain from the ORF-A of the PUFA synthase were 
also constructed and used in the complementation assays. For the assay, a single colony 
of each transformant was first grown in an ampicillin LB liquid medium at 37 ºC until 
an OD600 = 0.4 was reached. After that, 2 L of each culture were dotted on ampicillin 
LB plates containing 0.01% (wt/v) of L-arabinose (Shafiee et al., 2015; Terpe, 2006). 
The plates were cultured overnight at 37 ºC and 42 ºC, respectively.  
3.9 Complementation assays in E. coli tesAtesB mutant (ΔtesAtesB) with MAT-like 
domain 
The E. coli tesAtesB mutant (ΔtesAtesB) is a double-gene knockout generated by  
gene deletion of thioesterase I and II with chloramphenicol resistance marker (Baba et 
al., 2006; Cho & Cronan, 1993). According to Cho & Cronan (1994),  the thioesterase 
double mutant did not produce detectable growth phenotype nor different fatty acid 
profile when compared to the parental wild type (Cho & Cronan, 1994).    
 For the assay, the pBAD_MAT-like plasmid expressing the MAT-like domain 
and the empty pBAD were introduced in the mutant ΔtesAtesB and the parental wild 
type strain shown in Table 3.1. The mutant transformants were selected on 
chloramphenicol and ampicillin LB plates and the parental wild type transformant was 
selected on ampicillin plates. The positive mutant transformants and wild type clones 
were then grown in chloramphenicol and ampicillin and only ampicillin LB liquid 
medium, respectively, for lipid analysis. 
 
3.9.1 Lipid analysis 
For lipid analysis, single colonies of the wild type and ΔtesAtesB transformants 
were inoculated to 10 mL of chloramphenicol and ampicillin LB and grown at 37 ºC 
until an OD600 = 0.4 was reached. After that, expression was induced with 0.01% (wt/v) 
of L-arabinose and the strains were grown until an OD600 = 1 was reached. 
Subsequently, the cultures were centrifuged at 2200 g for 10 min, the total lipid from 
the biomass was extracted and analyzed. 
The lipids in the cells were extracted based on the method described by Folch et 
al., (1957). For the preparation of fatty acid methyl esters from the total lipids, 2 mL of 
1% (v/v) sulfuric acid in methanol was added to the total lipid extract and the mixture 
was incubated at 80 ºC for 1 hour. After that, the samples were cooled down on ice, 2 
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mL of hexane and 1 mL of potassium chloride 0.88% (wt/v) were then added. The 
mixture was centrifuged at 2200 g for 10 min and the hexane phase was transferred to a 
new tube and dried with N2 gas. After drying, 50 L of hexane was added to solubilize 
the transmethylated fatty acids and analysed by gas-chromatography (GC) in an Agilent 
Technologies 7890A System with a column DB-23. The GC program started with 160 
ºC and ended at 240 ºC. Ten L of 0.1 mg/L of heptadecaenoic (17:0) was used as an 
internal standard. For lipid class analysis, the total lipid was dissolved in 100 L of 
chloroform and loaded on a Whatman K6 silica gel plate. The plate was developed in a 
mixture of hexane, diethyl ether and acetic acid (70:30:1) and stained with 0.005% 
(wt/v) primulin in acetone-water (80:20). The lipid class bands were visualized under 
UV light.  
3.10 Expression of the MAT-like domain in the E. coli fadD mutants (fadD) 
After confirmation of the sequence, pET28a_MAT-like was transformed into the 
E. coli fadD strain. The transformant with the empty vector was used as a negative 
control. The transformants were selected on kanamycin LB plates. A single colony from 
the plate was inoculated to 5 mL of kanamycin LB liquid medium and incubated 
overnight at 37 C. An aliquot of 300 L of the overnight culture was inoculated into 30 
mL of LB medium and incubated at 37 C. After an OD600 of the culture reached 0.5, 
IPTG at the final concentration of 1 mM was used to induce the expression at 16 C 
(Terpe, 2006). To determine the expression of the protein, the cell pellet of 200 L 
culture was resuspended in 20 L of SDS-PAGE loading buffer (60 mM Tris-HCL pH 
6.8, 2% SDS, 0.1% bromophenol blue, 25% glycerine, 14.4 mM -mercaptoethanol) 
and analyzed by electrophoresis (Xie et al., 2017). Free fatty acids in the sample after 
24 h of induction were analyzed. 
 
3.10.1 Free fatty acid analysis 
Ten mL of the culture was centrifuged at 10000 rpm for 10 min for collecting 
cell pellets and supernatant. Total lipids from cell pellets were extracted following the 
protocol of Folch et al., (1957). Cells were disrupted using 1 mL of isopropanol at 80 ºC 
for 10 min. After the sample was cooled down to room temperature, 2 mL of 
chloroform and 1 mL of methanol were added. The mixture was centrifuged at 2200 
rpm for 10 min and the lower phase was transferred to a clean tube. Two mL of 
 26 
chloroform was added again to extract the residual lipids left in the sample. The lower 
phase was combined with the previous one. After that, 1 mL of KCl 0.88% (wt/v) was 
added to extract any contaminated hydrophilic compounds in the lipid extract. The 
mixture was centrifuged at 2200 rpm for 10 min, and the aqueous phase was removed as 
much as possible. The organic solvent phase of extractions was dried under N2 gas. Free 
fatty acids were selectively transmethylated to fatty acid methyl esters (FAMEs) using 
20 L of diazomethane (1:8, diazomethane:hexane) and 10 L of methanol at room 
temperature for 5 min. After the sample was dried under N2 gas, 50 L of hexane were 
added to solubilize the FAMEs and analyzed by gas-chromatography (Folch et al., 
1957). 
Free fatty acids were extracted from the culture by mixing 2 mL of the 
supernatant with the same volume of hexane and 500 L of NaCl saturated water (26.47 
%, w/w). The organic solvent phase of extractions was dried under N2 gas. Free fatty 
acids were selectively transmethylated as described previously for cell pellets. After the 
sample was dried under N2 gas, 50 L of hexane were added to solubilize the FAMEs 
and analyzed by gas-chromatography. Ten L of 0.1 mg/L of heptadecaenoic (17:0) 
was used as an internal standard. All analyzes were performed in triplicate. 
3.11 Expression of MAT-like domain in E. coli 
The plasmid pET28a_MAT-like was chemically transformed into E. coli BL21 
Star (DE3). A single colony of transformant was inoculated to 5 mL of kanamycin LB 
liquid medium and incubated overnight at 37 C. An aliquot of 200 L of the overnight 
culture was then inoculated into 20 mL LB liquid medium and incubated at 37 C until 
an OD600 = 0.5. Subsequently, 0.5 mM of IPTG was added to induce the expression 
(Terpe, 2006). The mixture was incubated at 16 ºC for 3 hours. After that, the culture 
was centrifuged at 4 ºC for 15 min to pellet cells. The cells were resuspended in 2 mL of 
ice-cold buffer (50 mM Tris-HCl, pH 8) and disrupted through a beadbeater. The 
mixture was centrifuged at 15000 rpm at 4 C for 15 min. Crude proteins in cell pellets 
and supernatant were separately resuspended in 200 L of SDS-PAGE loading buffer 
(60 mM Tris-HCL pH 6.8, 2% SDS, 0.1% bromophenol blue, 25% glycerine, 14.4 mM 
-mercaptoethanol) for electrophoresis (Xie, Meesapyodsuk, & Qiu, 2017). 
As the first expression of the domain in E. coli BL21 Star (DE3) was not 
successful, several other E. coli strains such as Rosetta (DE3), C43, C41, Arctic and 
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Shuffle (their genotypes described in Table 3.1) were attempted with varying induction 
conditions. E. coli SHuffle was found to be the best strain for the expression under the 
condition of 13 ºC overnight, and 1 mM IPTG induction.  
 
3.11.1 Enzymatic activity 
Thioesterases catalyze the release of acyl moieties from the phosphopantetheine 
of ACP or CoA (Smith & Tsai, 2007). The activity assay using the reagent 5,5’-
dithiobis(2-nitrobenzoic acid) (DTNB) was based on the reduction of DTNB (no colour) 
to 5-thio-2-nitrobenzoic acid (TNB) (yellow color) (Berge & Farstad, 1981) by CoASH 
released from acyl-CoA thioesters.  
18:0-, 18:1- and 18:2-CoA were purchased from Sigma-Aldrich (St. Louis, MO, 
USA) and 22:6-CoA was obtained from Avanti Polar Lipids, Inc. (Alabaster, AL, 
USA). 
The assay mixture (200 L) contained 30 mM HEPES, pH 7.5, 1 mM EDTA, 
0.3 mM DTNB, 100 M acyl-CoA and 300 g of total crude proteins. The blank 
reference for the assay was the same except for missing the proteins. The negative 
control was the assay using 300 g of total crude proteins from the strain with empty 
pET28a as the enzyme source. All the assays took place at 35 ºC for 30 min. The 
absorbance at 412 nm in the reaction was measured by NanoDrop™ 2000/2000c 
Spectrophotometer. Thioesterase activity was calculated on the
 
reported absorbance 
(Rodríguez-Guilbe et al., 2013). All assays were done in triplicate. 
3.12 Site-directed mutagenesis  
Overlapping PCR was employed for the site-directed mutagenesis of two 
residues S96 and H220 in the MAT-like domain. This method involves two sequential 
PCR reactions using two flanking primers (a and d) and two internal primers (b and c) 
to introduce the mutation of interest (+) as shown in Figure 3.3. Both PCR reactions 
were performed using the same setup and conditions specified in Table 3.3 and 3.4. The 
internal primers were used for the first PCR to generate two overlapping mutated 
nucleotide sequences, which were then used as templates for the second PCR to 
generate the mutated version of a gene product AD (Heckman & Pease, 2007; Reikofski 
& Tao, 1992). The primers used for the overlapping PCR are listed in Table 3.2. 
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Figure 3.3 Overlapping-PCR for the site directed mutagenesis Adapted from Heckman 
& Pease, 2007. 
 
3.12.1 Cloning and transformation of mutagenesis plasmids 
The amplification of the MAT-like domain with the mutated residues was 
performed following the same PCR reaction setup and thermocycling conditions as 
described above (see 3.7). The flanking primers used were pET28a F/R and the 
annealing temperature for all overlapping PCR was 68 ºC. The mutated MAT-like 
domain (S96A or H220A) was cloned into pET28a vector and the ligation reaction 
setup was the same as specified in Table 3.6. The recombinant plasmids were 
chemically transformed into E. coli Top10 and positive colonies were confirmed by 
colony PCR using the same reaction setup as specified in Table 3.7. The mutated 
sequence was confirmed by restriction digestion and sequencing. The correct constructs 
were chemically transformed into E. coli SHuffle and E. coli fadD strains (see 3.10). 
 
3.12.2 Expression and enzymatic activity 
 For the protein expression and enzymatic assay of MAT-like_S96A/H220A, the 
same procedures were used as described above (see 3.11). 
  
 29 
3.12.3 Free fatty acid analysis 
 The fatty acid analysis of transformants (fadD/pMAT-like_S96A/H220A) was 
performed as described above (see 3.10.1). 
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4. RESULTS 
4.1 Sequence analysis of a MAT-like domain in the PUFA synthase 
To dissect the authentic region of the MAT-like domain from the PUFA 
synthase for its functional analysis, homology search, homology modelling and multiple 
sequence alignment were employed to delimit the domain in the PUFA synthase. The 
results showed that the region of the MAT-like domain was located between amino 
acids 1048 and 1390 in the Subunit-B, belonging to the PfaB group proteins with the 
functions of hydrolases and transferases including discrete MATs for Type II fatty acid 
synthesis in bacteria and MAT domains of PUFA synthases in the biosynthesis of 
VLCPUFAs in pressure and cold-adapted deep-sea bacteria (Orikasa et al., 2009). All 
these sequences possessed an / hydrolase fold with a conserved motif GXSXG in the 
catalytic site located in a nucleophilic elbow typical for serine hydrolases and 
transferases. A highly conserved histidine residue at position 220 probably important 
for the enzymatic activity was also observed in the structure. The MAT-like domain 
shared a slightly higher amino acid identity to discrete MAT proteins from E. coli (Serre 
et al., 1995), Coxiella burnetti (Franklin et al., 2015) and Streptococcus pneumoniae 
(Hong et al., 2010) (19.9%, 17.6% and 19.9%, respectively) than the MAT domain in 
Subunit-A of the PUFA synthase (13.8%) (Figure 4.1). In addition, this domain also 
possessed sequence similarity to a group of discrete thioesterases such as an acyl-ACP 
thioesterases in Amycolaptosis mediterranei (August et al., 1998) (16.8 %) and 
Streptomyces coelicolor (Whicher et al., 2011) (16.4 %) (Figure 4.2) with the conserved 
motif GXSXG. 
Figure 4.1 Partial sequence alignment of the MAT-like domain with discrete MAT 
enzymes. 
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Figure 4.2 Sequence alignment of the MAT-like domain with discrete TE sequences. 
4.2 Expression of the MAT-like domain in an E. coli FabD mutant  
To determine the function of the MAT-like domain, this domain was expressed 
as a standalone protein in an E. coli FabD mutant defective in malonyl-CoA:ACP 
transacylase (MAT) activity. As MAT was essential for fatty acid synthesis, only a 
temperature-sensitive mutant of this gene was available in E. coli for the expression. 
The wild type strain (WT) with the empty vector could grow at both permission and 
non-permission temperatures (37 ºC and 42 ºC), while the mutant with the MAT-like 
domain from ORF-B (Mutant+MAT), similar to the mutant with the empty vector 
(Mutant), could grow at 37 ºC, but not at 42 ºC. On the other hand, the mutant with 
either wild type discrete MAT gene FabD (Mutant+FabD) or authentic MAT domain 
from ORF-A (Mutant+MAT) could effectively grow at both 37 ºC and 42 ºC. These 
results showed that the MAT-like domain is incapable of complementing the defective 
MAT phenotype (Figure 4.3), thus it does not function as a malonyl-CoA:ACP 
transacylase. 
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Figure 4.3 Plate complementation test of the MAT-like domain in an E. coli fabD 
mutant. WT: parental wild type of the mutant. 
4.3 Expression of the MAT-like domain in an E. coli tesAtesB mutant  
E. coli possessed two major acyl-thioesterases (TesA and TesB), but neither was 
essential.  No changes on growth phenotype and fatty acid profile could be detected in 
the double mutant (tesAtesB) (Cho & Cronan, 1993). To further interrogate whether 
the MAT-like domain could impose any changes on lipid class and fatty acid profile, the 
domain was expressed as a standalone protein in the double mutant.  The total fatty acid 
analysis did not reveal any difference among three strains: parental wild type, mutant 
with the empty vector and mutant with the MAT-like domain (Figure 4.4). Lipid class 
analysis (Figure 4.5) also showed that no difference could be observed either on the 
type and amount of lipid classes among three strains. 
 
  
Figure 4.4 Total fatty acid profile of E. coli ΔtesAtesB with the MAT-like domain and 
the empty vector, and its parental wild type. Values are reported as means  standard 
deviations for three biological replicates. 
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Figure 4.5 Lipid class analysis by TLC. TAG: triacylglycerol, FFA: free fatty acids, 
DAG: diacylglycerol, PL: phospholipids, WT: parental strain with pBAD empty vector, 
ΔtesAtesB: mutant strain with the empty vector, ΔtesAtesB/pMAT-like: mutant strain 
with pBAD expressing the MAT-like domain. 
4.4 Expression of the MAT-like domain in an E. coli fadD mutant  
To investigate if the MAT-like domain has any impact on the production of free 
fatty acids, another E. coli mutant (fadD) defective in acyl-CoA synthetase activity was 
exploited to express the domain. The rationale was that the MAT-like domain, if 
functioning as a thioesterase, would increase the accumulation of free fatty acids in the 
mutant where the defect in acyl-CoA synthetase would prevent fatty acid degradation 
through β-oxidation. Experimental results showed that the expression of the MAT-like 
domain in the mutant increased the production of free fatty acids by approximately 50% 
in cell pellets (inside cells) (Table 4.1, Figure 4.6) and more than 30% in supernatants 
(secreted outside of cells) relative to the mutant control (Table 4.1, Figure 4.7). Among 
all the free fatty acids produced, the major increase was observed in 11-cis-octadecenoic 
acid (18:1-11), a monounsaturated long chain fatty acid (Figures 4.8 and 4.9). The 
mutant expressing the MAT-like domain produced more than three times of 18:1-11 
than the mutant with the empty vector (2.49 vs 0.76 mg/L) inside the cells. These results 
indicate that the MAT-like domain could function as a thioesterase by increasing free 
fatty acids production on the background of defective acyl-CoA synthetase. 
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Figure 4.6 GC analysis of FAMEs prepared from cell pellets of ΔfadD and 
ΔfadD_MAT-like. 
 
 
Figure 4.7 GC analysis of FAMEs prepared from supernatants of ΔfadD and 
ΔfadD_MAT-like. 
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Figure 4.8 Free fatty acid profile in the cell pellets of fadD mutant with the MAT-like 
domain. Values are reported as means  standard deviations for three biological 
replicates. Means with different letters were statistically different according to an 
unpaired t test (P<0.05).  
 
   
Figure 4.9 Free fatty acid profile in the supernatant of fadD mutant with the MAT-like 
domain. Values are reported as means  standard deviations for three biological 
replicates. Means with different letters were statistically different according to an 
unpaired t test (P<0.05).  
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Table 4.1 Free fatty acid content in the E. coli fadD expressing the MAT-like domain. 
Values are reported as means  standard deviations for three biological replicates. 
Means with different letters are statistically different according to an unpaired t test 
(P<0.05).  
  
FFA content [mg/L] 
  
∆fadD ∆fadD_MAT-like 
Source 
Cells 3.43 ± 0.22
a 
4.98 ± 0.003
b 
Supernatant 1.29 ± 0.02
a 
1.77 ± 0.13
b 
 
4.5 In vitro activity assays of MAT-like domain  
To confirm that the MAT-like domain functioned as a thioesterase, this domain 
was first expressed as a standalone protein in an E. coli BL21 Star (DE3) (Figure 4.10), 
which was then used as the enzyme source for thioesterase assays using a method based 
on reduction of 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB) to 5-thio-2-nitrobenzoic 
acid (TNB) by CoASH. However, due to the low solubility of the expressed protein in 
the strain, the enzymatic assay was unsuccessful. To improve the expression, other E. 
coli strains such as Rosetta (DE3), C43, C41, Arctic and SHuffle (Figure 4.10) were 
subsequently attempted. It appeared that the SHuffle strain with enhanced capacity for 
appropriate folding provided a slightly better result in expressing the domain. 
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Figure 4.10 SDS-PAGE of protein expression of MAT-like (38 kDa) in E. coli BL21 
Star (DE3) and SHuffle. CP: cell pellet, S: supernatant.  
 
In vitro thioesterase activity assays using the crude protein extract from the E. 
coli SHuffle expressing the MAT-like domain as an enzyme source showed that the 
MAT-like domain could hydrolyze the four acyl-CoAs substrates tested, steroyl-CoA 
(18:0-CoA), octadecenoyl-CoA (18:1-CoA), octadecadienoyl-CoA (18:2-CoA) and 
docosahexaenoyl(DHA)-CoA (22:6-CoA), and the highest activity was found towards 
docosahexaenoyl-CoA, followed by 18:2-CoA, 18:0-CoA and 18:1-CoA after 
normalization against the control  (Figure 4.11). This result indicates that the MAT-like 
domain indeed possesses acyl thioesterase activity. 
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Figure 4.11 Thioesterase activity of MAT-like domain towards four acyl-CoA 
substrates. Values are reported as means  standard deviations for three biological 
replicates. Means of SHuffle_MAT-like with different letters were statistically different 
according to a one-way ANOVA (P<0.05). Means between SHuffle and SHuffle MAT-
like activities were statistically different according to an unpaired t test. 
4.6 Mutagenesis analysis of the MAT-like domain 
According to sequence analysis, two conserved residues S96 and H220 were 
found among the MAT-like domain and related sequences (Figures 4.1 and 4.2). To 
investigate if the two residues are involved in the catalysis, they were individually 
replaced by alanine through site-directed mutagenesis. Experimental results showed that 
the individual substitution of the two residues resulted in the reduction of their 
thioesterase activities towards DHA-CoA, the most preferred substrate, by about 80% 
relative to the wild type domain protein (Table 4.2). Furthermore, the expression of the 
two mutant proteins in the E. coli fadD strain also resulted in substantial reduction of 
free fatty acids relative to those of controls expressing the empty vector and wild type 
domain (Table 4.3).  The extent of reduction of free fatty acids in the cells was more 
obvious in S96A than H220A. These results indicate these two residues indeed play 
important roles in catalytic activity and support the hypothesis that the MAT-like domain 
functions as a thioesterase. 
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Table 4.2 Thioesterase activities of the mutant MAT-like domain towards DHA-CoA. 
Values are reported as means  standard deviations for three biological replicates. 
Means with different letters were statistically different according to an unpaired t test 
(P<0.05). 
Protein µmol TNB/min/mg protein 
MAT-like 3.08 ± 0.17
a 
MAT-like S96A 0.68 ± 0.17
b 
MAT-like H220A 0.71 ± 0.21
b 
 
Table 4.3 Free fatty acid contents in fadD/pMAT-likeS96A and fadD/pMAT-
likeH220A. Values are reported as means  standard deviations for three biological 
replicates. Means with different letters were statistically different according to an 
unpaired t test (P<0.05). 
  
 Strain FFA content [mg/L] 
  
∆fadD ∆fadD/pMAT-like 
∆fadD/pMAT-like 
S96A 
∆fadD/pMAT-like 
H220A 
Source 
Cells 3.43 ± 0.22
a 
4.98 ± 0.003
b 
1.75±0.1
c 
2.88±0.18
d 
Supernatant 1.29 ± 0.02a
 
1.77 ± 0.13
c 
1.32±0.03
a 
1.05±0.05
b 
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5. DISCUSSION  
 
PUFA synthases have been identified in marine microorganisms such as 
Shewanella sp., Photobacterium sp., Schyzochytrium sp., and Thraustochytrium sp. 
(Arts et al., 2009). In Thraustochytrium, the PUFA synthase comprises three large 
subunits each with multiple catalytic domains predicted on the presence of characteristic 
active sites (Meesapyodsuk & Qiu, 2016). However, the exact boundaries and functions 
of these domains are not completely known. This study undertook sequence analysis 
and heterologous expression approaches to investigate the function of a malonyl-
CoA:ACP transacylase (MAT)-like domain from the PUFA synthase in 
Thraustochytrium sp. 21685.  
Sequence analysis using a combination of bioinformatics tools such as 
homology search, homology modelling and sequence alignment indicates the MAT-like 
domain resides between 1048 and 1390 amino acids in the ORF-B. A GXSXG motif, 
and a histidine residue are conserved among the MAT-like domain and related 
sequences, such as MAT and TE proteins. The serine at position 96, and the histidine at 
position 220 are conserved in the sequences (Pazirandehs et al., 1991) and might be part 
of a catalytic triad in the active site for catalysis, as the substitutions of these two 
residues with alanine in the domain almost abolished the activity shown by an in vitro 
assay using the crude extract of the expression in E. coli as an enzyme source (Kraut, 
1977). The residual activity left in the assay could be due to compensated effects of 
endogenous thioesterases in the host. In fact, the expression of the two mutated MAT-
like domains in an E. coli mutant (fadD) defective in acyl-CoA synthetase activity 
confirms that the mutated MAT-like domains are not functional, as the level of free 
fatty acids in the mutant strain expressing the mutated domains is even lower than those 
in the strains with the empty vector and the wild type domain. The lower production of 
free fatty acids in the negative control (fadD/pET28a) could be due to the dominant 
negative mutation effect (Herskowitz, 1987), as functional endogenous E. coli 
thioesterases and non-functional mutated MAT-like domains could compete for the 
same substrate, leading to the reduced production of free fatty acids. 
To functionally analyze the MAT-like domain, it was first expressed as a 
standalone protein in an E. coli temperature sensitive MAT mutant (fabD
ts
). This mutant 
has been previously used to examine the function of predicted MAT proteins by 
complementation tests (Sun et al., 2012). The result showed that it did not function as a 
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MAT to complement the defective phenotype of the mutant, although the MAT-like 
domain shares the highest amino acid identity to malonyl CoA:ACP transacylase 
proteins. Next, an E. coli double mutant (ΔtesAtesB) was employed to express the 
domain, as it has the second highest sequence similarity to thioesterases. However, the 
expression in the mutant did not produce any detectable changes on growth phenotype 
and lipid/fatty acid profile, similar to the previous result observed between the mutant 
and the wild type strain (Cho & Cronan, 1993). Subsequently, the MAT-like domain 
was expressed in another E. coli mutant (ΔfadD) where acyl-CoA synthetase gene was 
deleted. Previously, this mutant has been used for enhancing the production of free fatty 
acids in bacteria (Lennen & Pfleger, 2012; Steen et al., 2010; Torella et al., 2013; X. 
Zhang et al., 2011), as inactivation of acyl-CoA synthetase blocks the formation of acyl-
CoA from free fatty acids, thereby preventing fatty acid degradation through β-
oxidation. E. coli produces fatty acids principally for the biosynthesis of membrane 
lipids and normally does not accumulate a high level of free fatty acids (X. Zhang, Li, 
Agrawal, & San, 2011). Overproduction of free fatty acids by expressing the MAT-like 
domain in this mutant is indicative of thioesterase activity. Finally, in vitro assays using 
the protein expressed in an E. coli strain with enhanced capacity for appropriate protein 
folding confirmed the thioesterase activity of the MAT-like domain on acyl-CoAs. 
In marine Thaustochytrids, VLCPUFAs are solely synthesized by an anaerobic 
pathway catalyzed by a PUFA synthase (Metz et al., 2009). After synthesis, 
VLCPUFAs are released from a PUFA synthase as free fatty acids probably catalyzed 
by a thioesterase activity of a domain inside the PUFA synthase (Metz et al., 2009). 
However, identity of this domain has not been determined previously. The 
complementation test in this study confirms that the MAT-like domain does not 
function as a MAT. In addition, the increased production of free fatty acids in an E. coli 
acyl-CoA synthetase mutant expressing the domain is indicative of thioesterase activity 
by releasing free fatty acids from their thioesters. In vitro enzymatic assays using the 
domain protein as an enzyme source demonstrates that this domain can hydrolyze four 
acyl thioesters with the highest activity towards a thioester of DHA, the most abundant 
fatty acid produced in Thraustochytrium. Collectively, these results support the notion 
that the MAT-like domain of the PUFA synthase from Thraustochytrium possesses 
thioesterase activity and it might be involved in catalyzing the last step of the 
VLCPUFA biosynthesis by releasing freshly synthesized VLCPUFAs from their 
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thioesters attached to ACP domains of the PUFA synthase into a pool of free fatty acids 
for subsequent metabolisms. 
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6. CONCLUSION 
 
This research investigated the function of a MAT-like domain of the PUFA 
synthase in Thraustochytrium. Sequence analysis showed that the MAT-like domain 
was located between amino acids 1048 and 1390 in the subunit-B of the PUFA 
synthase. A conserved motif GXSXG found in / hydrolases was identified in the 
sequence, and mutation of the serine residue inside the motif almost abolished the 
catalytic activity in the in vitro assay, indicating this motif is essential for the activity. 
Expression of the MAT-like domain in an E. coli FabD temperature-sensitive mutant 
defective in MAT activity did not complement the phenotype; while the expression of 
the MAT from the subunit-A could restore the growth at the non-permission 
temperature (42 ºC), indicating that this MAT-like domain does not function as a MAT.  
Expression of MAT-like domain in an E. coli tesAtesB double mutant deficient in 
thioesterase did not produce any change in growth phenotype or lipid profile compared 
to the wild type, as seen previously. Expression of the MAT-like domain in an E. coli 
fadD defective in acyl-CoA synthetase activity increased the production of free fatty 
acids both inside and outside cells, indicating potential thioesterase activity. Finally, in 
vitro assays using four acyl-CoAs and the crude protein extract containing the MAT-
like domain showed that it possessed thioesterase activity towards 18:0-CoA, 18:1-
CoA, 18:2-CoA and 22:6-CoA, and DHA-CoA is the preferred substrate. These results 
indicate that the MAT-like domain of the subunit-B of the PUFA synthase in 
Thraustochytrium does not function as a MAT, and it is most likely that it function as a 
thioesterase. This activity might be employed in releasing synthesized VLCPUFAs 
attached to ACP domains of the PUFA synthase to free fatty acids in Thraustochytrium.  
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7. FUTURE DIRECTIONS 
 
Through complementation expressions in E. coli mutant strains and in vitro 
assays, a malonyl-CoA:ACP transacylase (MAT)-like domain of the PUFA synthase 
from was shown to possess thioesterase activity, which might be involved in catalyzing 
the last step of DHA biosynthesis by releasing freshly-synthesized VLCPUFAs from 
the PUFA synthase in Thraustochytrium.   To prove that the MAT-like domain is the 
one responsible for the activity in vivo, a knock-out Thraustochytrium mutant of this 
domain in the PUFA synthase is required for assays. If the MAT-like knockout mutant 
cannot synthesize DHA due to being unable to release DHA from the ACP domains, it 
would confirm that this domain is essential for the biosynthesis of DHA in 
Thraustochytrium. 
VLCPUFAs particularly DHA and EPA are well recognized for their health 
benefits. As marine fish for these fatty acids are overexploited, metabolic engineering of 
oilseed crops and oily microorganisms might provide a promising alternative source for 
the fatty acids. A future direction for implementing this strategy can consider to design 
new PUFA synthases by recombining essential domains functionally characterized by 
research such as this one for effective production of VLCPUFAs in heterologous 
systems.  
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